> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# QuVa Pharma FDA-483
- URL: https://www.fdaweb.com/quva-pharma-fda-483/
- Published: 2023-04-05T12:00:00.000Z
- Updated: 2026-09-14T18:24:01.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5154144

FDA has released the form FDA-483 issued following a 7/11-8/18/22 inspection at QuVa Pharma, a Sugar Land, TX, outsourcing facility. The three inspection observations were:

- employees engaged in the manufacture and processing of a drug product lack the training required to perform their assigned functions;
- determination of conformance to appropriate written specifications for acceptance of drug products is deficient; and
- the written stability testing program is not followed.